FILTER BY:
Details
A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors
Address: 55 Fruit St, Boston, MA 02114, USA
Phone: 877-451-7009
Mesothelioma Type:
- Pleural: True
- Peritoneal: True
- Pericardial: True
- Tunica Vaginalis: True
Type: Epitheliod, Sarcomatoid, Biphasic
Condition: Mesothelioma
Description: The purpose of this study is to characterize the safety and tolerability of IAG933 in patients with mesothelioma, NF2/LATS1/LATS2 mutated tumors and tumors with functional YAP/TAZ fusions and to identify the maximum tolerated dose and/or recommended dose.
Research Center: Massachusetts General Hospital Massachusetts General Hospital
Treatment Interventions: DRUG: IAG933
Potential Impact: Fake Data
Clinical Trial Number: NCT04857372
Phase: Phase 1
Status: Recruiting
